Cargando…
Lipid nanoparticles as delivery vehicles for the Parietaria judaica major allergen Par j 2
Parietaria pollen is one of the major causes of allergic reaction in southern Europe, affecting about 30% of all allergic patients in this area. Specific immunotherapy is the only treatment able to modify the natural outcome of the disease by restoring a normal immunity against allergens. The prepar...
Autores principales: | Bondì, Maria Luisa, Montana, Giovanna, Craparo, Emanuela Fabiola, Di Gesù, Roberto, Giammona, Gaetano, Bonura, Angela, Colombo, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230564/ https://www.ncbi.nlm.nih.gov/pubmed/22162654 http://dx.doi.org/10.2147/IJN.S24264 |
Ejemplares similares
-
Expression and characterization of recombinant Par j 1 and Par j 2 resembling the allergenic epitopes of Parietaria judaica pollen
por: Dorofeeva, Yulia, et al.
Publicado: (2019) -
Anti-inflammatory effects of pre-seasonal Th1-adjuvant vaccine to Parietaria judaica in asthmatics
por: Scichilone, Nicola, et al.
Publicado: (2011) -
Microsatellite primers in Parietaria judaica (Urticaceae) to assess genetic diversity and structure in urban landscapes(1)
por: Bossu, Angèle, et al.
Publicado: (2014) -
Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
por: Di Gesù, Roberto, et al.
Publicado: (2018) -
Polyaspartamide-Based Nanoparticles Loaded with Fluticasone Propionate and the In Vitro Evaluation towards Cigarette Smoke Effects
por: Craparo, Emanuela Fabiola, et al.
Publicado: (2017)